Heart Attack (Myocardial Infarction) Clinical Trials

A listing of Heart Attack (Myocardial Infarction) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 18 clinical trials
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

This is a study in adults who had a heart attack (myocardial infarction). The purpose of this study is to find out whether a medicine called empagliflozin helps to lower the chances of having to

angiography
myocardial infarction
infarct
diabetes
stemi
  • 0 views
  • 19 Jul, 2021
  • 149 locations
Beta Blocker Interruption After Uncomplicated Myocardial Infarction

ABYSS is a national, multicenter, randomised, open label trial using the PROBE study design, that will evaluate the non-inferiority of the interruption of B therapy after an uncomplicated MI after six months or more of follow-up compared to the continuation of B evaluated by the primary endpoint or death, MI, …

q waves
beta blockers
myocardial infarction
infarct
acute myocardial infarction
  • 77 views
  • 26 Jul, 2021
  • 1 location
Dapagliflozin Effects on Cardiovascular Events in Patients With an Acute Heart Attack

This study will evaluate the effect of dapagliflozin versus placebo, given once daily in addition to Standard of Care (SoC) therapies for patients with myocardial infarction (MI), for the

cardiac mri
myocardial infarction
infarct
ventriculogram
heart failure
  • 0 views
  • 25 Jul, 2021
  • 87 locations
Myocardial Ischemia and Transfusion

The purpose of this study is to compare two red blood cell transfusion strategies (liberal and restrictive) for patients who have had an acute myocardial infarction and are anemic.

ischemia
myocardial infarction
infarct
acute myocardial infarction
blood transfusion
  • 378 views
  • 29 Jul, 2021
  • 133 locations
Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

[MACE - cardiovascular (CV) death, myocardial infarction (MI), and stroke] in subjects with acute coronary syndrome (ACS) diagnosed with either ST-segment elevation myocardial infarction (STEMI) or non

myocardial infarction
infarct
diabetes
arterial disease
stroke
  • 1118 views
  • 29 Jul, 2021
  • 3431 locations
Myo-inositol for Reduction of Insulin Therapy in Gestational Diabetes Mellitus

GDM and health accessibility may be unequal. MYO-INOSITOL (MI) is an oral dietary supplement, which reduces insulin resistance. Women with GDM are deficient in MI. MI supplementation safely

plasma glucose
self-monitoring of blood glucose
hyperglycemia
diabetes
insulin
  • 0 views
  • 27 Jul, 2021
  • 1 location
Efficacy and Safety of MEDI6570 in Patients With a History of Myocardial Infarction

A Phase IIB Parallel group Study to Evaluate the Efficacy and Safety of MEDI6570 in Participants with a Prior Myocardial Infarction.

myocardial infarction
infarct
  • 0 views
  • 17 Jul, 2021
  • 69 locations
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

The primary objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background antiplatelet therapy in patients who develop new-onset post-operative atrial fibrillation (POAF) after isolated coronary artery bypass graft (CABG) surgery. All patients with a qualifying …

thromboembolism
anticoagulants
aspirin
atrial fibrillation
vitamin k antagonist
  • 112 views
  • 26 Jul, 2021
  • 80 locations
VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome

The objective of the study is to establish a de-scaling strategy of P2Y12 inhibitors (P2Y12 i) with a decrease in hemorrhagic events without increasing ischemic complications based on a Platelet Function Test (PFT).

antiplatelet therapy
clopidogrel
acute coronary syndrome
ticagrelor
prasugrel
  • 0 views
  • 30 Jul, 2021
  • 3 locations
Aspirin to Target Arterial Events in Chronic Kidney Disease

This study aims to find out whether people with chronic kidney disease [CKD] should take low dose aspirin to reduce the risk of first heart attack or stroke (cardiovascular disease [CVD]). CKD is common and is associated with an increased risk of CVD. CVD is caused by small blood clots …

primary prevention
nephropathy
myocardial infarction
aspirin
proteinuria
  • 0 views
  • 26 Jul, 2021
  • 1 location